https://www.africainthenews.com/article/906624216-1922-revisited-brings-contemporary-performance-into-dialogue-with-venice-biennale-history Africa In The News en PressRelease 2026-04-19T10:19:52+00:00 1922 Revisited Brings Contemporary Performance Into Dialogue With Venice Biennale History https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835740-1922-revisited-artists-venice-2551x3837.jpeg https://www.africainthenews.com/article/906535945-tinsel-news-examines-liberia-s-transition-from-conflict-minerals-in-fifth-sudan-series-installment Africa In The News en PressRelease 2026-04-18T16:46:34+00:00 Tinsel News Examines Liberia's Transition From Conflict Minerals in Fifth Sudan Series Installment https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835649-tinsel-news-photo-by-emmanuel-i-2000x1335.jpeg https://www.africainthenews.com/article/906378336-boundless-bio-presents-preclinical-breast-cancer-data-from-its-oral-kinesin-degrader-program-at-2026-aacr-annual-meeting Africa In The News en PressRelease 2026-04-17T20:49:47+00:00 Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://www.africainthenews.com/article/906376026-zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Africa In The News en PressRelease 2026-04-17T20:15:00+00:00 Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.africainthenews.com/article/906375383-alx-oncology-reports-inducement-grant-as-permitted-by-the-nasdaq-listing-rules Africa In The News en PressRelease 2026-04-17T20:05:00+00:00 ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.africainthenews.com/article/906375662-camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Africa In The News en PressRelease 2026-04-17T20:05:00+00:00 CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://www.africainthenews.com/article/906376697-pyxis-oncology-to-present-new-preclinical-data-showing-synergistic-anti-tumor-activity-in-a-hnscc-model-with-mamicvo-in-combination-with-anti-pd-1-at Africa In The News en PressRelease 2026-04-17T20:05:00+00:00 Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://www.africainthenews.com/article/906377182-revolution-medicines-announces-closing-of-concurrent-upsized-public-offerings-with-aggregate-gross-proceeds-of-approximately-2-2-billion-including Africa In The News en PressRelease 2026-04-17T20:02:00+00:00 Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.africainthenews.com/article/906350165-pheast-therapeutics-reports-initial-phase-1a-data-showing-early-clinical-activity-and-target-engagement-for-phst001-at-aacr-2026 Africa In The News en PressRelease 2026-04-17T19:00:00+00:00 Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026 https://ml.globenewswire.com/media/f27ab630-f23c-44f6-aae6-6fae240628af/small/pheast-logo-full-color-gradient-high-res-jpg.jpg https://www.africainthenews.com/article/906350188-zymeworks-presents-new-preclinical-data-at-aacr-2026-highlighting-broad-antibody-drug-conjugate-programs-including-novel-ras-targeting-platform Africa In The News en PressRelease 2026-04-17T19:00:00+00:00 Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png